374
J. Skarz; ewski et al. / Tetrahedron: Asymmetry 13 (2002) 369–375
substrate), dried (MgSO4) and evaporated under
reduced pressure. The residue was purified by column
chromatography, eluted with tert-BuOMe:CH2Cl2 3:2,
and recrystallized (CH2Cl2–hexane).
4.6.2.3. 4-Phenylsulfinylbutane-1,2-diol 5b. D.m. 1H
NMR (CDCl3): l=1.72–1.95 (m, 2H, CH2), 2.86–3.18
(m, 2H, CH2), 3.27 (s, 2H, 2×OH), 3.44–3.49 (m, 2H),
3.70–3.74 (m, 1H, CH), 7.50–7.91 ppm (m, 5H, ArH).
13C NMR (CDCl3): 21.0, 21.1, 48.2, 48.3, 61.4, 65.5,
65.8, 119.3, 124.5, 126.4, 138.0 ppm. IR (film): 692, 996,
1086, 1405, 1668, 2927, 3364 cm−1. Rf=0.15 (t-BuOMe/
CHCl3, 3:2).
4.6.2. Typical procedure for AD-reactions.6 These reac-
tions were run as follows: The substrate 1, 2 or 4 (1
mmol) was dissolved in 1:1 water/t-BuOH mixture (10
mL) and cooled to 0°C. Then, the commercial (Aldrich)
AD-mix a or AD-mix b (1.4 g) and methanesulfon-
amide (1.0 mmol, 95.1 mg, except for substrates with a
terminal double bond) were added and the mixture was
stirred for 48 h at 0°C. Anhydrous sodium sulfite (0.01
mol, 1.26 g) was introduced and after 1 h stirring
dichloromethane (15 mL) was added. The layers were
separated and the aqueous phase was extracted with
dichloromethane (3×10 mL). The combined organic
extracts were washed with 2 M KOH (3 mL, in the case
of non-terminal substrates), dried (MgSO4) and evapo-
rated under reduced pressure. The residue was purified
by column chromatography, eluted with tert-
BuOMe:CH2Cl2 3:2, and recrystallized (CH2Cl2–
hexane).
1
4.6.2.4. 4-(2-Tolylsulfinyl)butane-1,2-diol 5c. D.m. H
NMR (CDCl3): l=1.81–1.90 (m, 2H, CH2), 2.37 (s,
3H, CH3), 2.82–2.89 (m, 1H, CH2), 3.03–3.10 (m, 1H,
CH2), 3.44–3.50 (m, 1H), 3.59–3.74 (m, 3H, 2×OH,
CH2), 3.60–3.86 (m, 1H, *CH), 7.19–7.21 (d, 1H, ArH,
J=6.8 Hz), 7.36–7.45 (m, 2H, ArH), 7.84–7.86 ppm (d,
1H, ArH, J=6.9 Hz). 13C NMR (CDCl3): 18.2, 18.2,
26.3, 26.3, 51.0, 51.4, 66.4, 66.4, 70.4, 70.7, 123.9, 124.1,
127.2, 127.2, 130.8, 130.8, 130.9, 130.9, 134.4, 134.5,
140.7, 140.9 ppm. IR (film): 758, 1020, 1455, 1472,
1656, 2925, 3369 cm−1. Rf=0.29 (t-BuOMe/CHCl3/
MeOH, 2:1:1).
4.7. Preparation of sulfones12
A solution of sulfoxide 3 (1 mmol) in methanol (20 mL)
was treated with Oxone® (675 mg, 1.1 mmol—in the
case of sulfide 1 oxidation the amount of oxidant was
doubled) in water (10 mL). The reaction mixture was
stirred at room temperature for 2 h. The solution was
extracted with dichloromethane (30 mL), the organic
phase was separated, dried (Na2SO4), and evaporated
under reduced pressure. The products were recrystal-
lized or chromatographed on silica gel.
4.6.2.1. 1-Phenyl-4-phenylsulfanylobutane-1,2-diol 3a.
Mp=56–58°C (petroleum ether/CH2Cl2). (R,R)-(3a):
[h]D20=+49 (0.60, CH2Cl2, 76% e.e.), (S,S)-(3a): [h]2D0=
1
−46 (0.48, CH2Cl2, 71% e.e.). H NMR (CDCl3): l=
1.52–1.77 (m, 2H), 2.63 (s, 2H, 2×OH), 2.88–2.98 (m,
1H), 3.03–3.16 (m, 1H), 3.87–3.94 (m, 1H), 4.42–4.44
(d, 1H, J=6.8 Hz), 7.14–7.36 ppm (m, 10H, ArH).
Dl=0.122 ppm in the presence of Eu(hfc)3 in CCl4
(CH2CHOH). 13C NMR (CDCl3): 30.3, 31.9, 74.6, 77.8,
126.0, 126.8, 128.2, 128.6, 128.8, 129.4, 135.9, 140.7
ppm. IR (KBr): 702, 739, 910, 1052, 1078, 1199, 1439,
1454, 1584, 2971, 3387 cm−1. Rf=0.50 (t-BuOMe/
CHCl3, 3:2). Anal. calcd for: C16H18O2S (M=274.38):
C, 70.05; H, 6.62; S, 11.66; found C, 70.28; H, 6.90; S,
11.46%.
4.7.1. 1-Phenyl-4-phenylsulfonylbut-1-ene 4a. Yield 91%.
1
Mp=68–69.5°C (MeOH). H NMR (CDCl3): l=2.63–
2.70 (m, 2H, CH2), 3.24–3.29 (m, 2H, CH2), 6.02–6.12
(m, 1H, -CHꢀCH-), 6.39–6.45 (d, 1H, -CHꢀCH-, J=
15.8 Hz), 7.25–7.29 ppm (m, 5H, ArH), 7.57–7.68 ppm
(m, 3H, ArH), 7.95–7.98 ppm (d, 2H, ArH, J=7.7 Hz).
13C NMR (CDCl3): l=26.3, 55.7, 125.1, 126.1, 127.5,
128.1, 128.5, 129.3, 132.4, 133.7, 136.6, 139.0 ppm. IR
(KBr): 536, 566, 682, 741, 795, 976, 1086, 1139, 1230,
1282, 1294, 1449, 1480, 1585, 1597, 2919, 3031, 3081
cm−1. Anal. calcd for: C16H16O2S (M=272.36): C,
70.56; H, 5.92; S, 11.75; found C, 70.40; H, 5.74; S,
11.47%.
4.6.2.2. 1-Phenyl-4-phenylsulfinylbutane-1,2-diol 5a.
Isomer l: mp=134–135°C (hexane/CH2Cl2). (R,R,R)-
5a: [h]2D0=+126 (0.40, CH2Cl2, >98% e.e.), (S,S,S)-5a:
[h]2D0=−125 (0.34, CH2Cl2, >98% e.e.). 1H NMR
(CDCl3): l=1.77–1.87 (m, 2H, CH2), 2.84–3.05 (m, 2H,
CH2), 3.13 (s, 2H, 2×OH), 3.78–3.84 (m, 1H, -CH),
4.44–4.46 (d, 1H, -CH, J=6.8 Hz), 7.33–7.37 (m, 5H,
ArH), 7.49–7.57 (m, 5H, ArH); 13C NMR (CDCl3):
l=26.5, 53.6, 74.3, 77.6, 124.0, 126.9, 128.2, 128.6,
129.3, 131.1 ppm. Mixture of l and u: 1H NMR
(CDCl3): l=1.70–1.75 and 1.77–1.87 (two m, 2H,
CH2), 2.84–3.05 (m, 2H, CH2), 3.13 (br. s, 2H, 2×OH),
3.69–3.74 and 3.78–3.84 (two m, 1H, -CH), 4.39–4.42
and 4.44–4.46 (two d, 1H, -CH, J=7.2 Hz and J=6.8
Hz, respectively), 7.32–7.48 (m, 5H, ArH), 7.48–7.57
ppm (m, 5H, ArH). 13C NMR (CDCl3): l=26.5, 26.9,
53.5, 53.6, 74.3, 74.5, 77.6, 77.9, 124.0, 124.2, 125.9,
126.9, 127.0, 128.2, 128.6, 128.6, 129.3, 131.1 ppm. IR
(KBr): 698, 745, 1015, 1044, 1181, 1442, 2911, 3361
cm−1. Rf=0.23 (t-BuOMe/CHCl3, 3:2). Anal. calcd for:
C16H18O3S (M=290.38): C, 66.18; H, 6.25; S, 11.04;
found C, 65.90; H, 6.20; S, 11.30%.
4.7.2.
(R,R)-1-Phenyl-4-phenylsulfonylbutane-1,2-diol
6a. Mp=90–92°C (CH2Cl2/hexane). [h]2D0=+17 (0.30,
CH2Cl2, 89% e.e.). 1H NMR (CDCl3): l=1.78–1.80 (m,
2H), 2.68 (s, 2H, 2×OH), 3.04–3.20 (m, 1H), 3.24–3.34
(m, 1H), 3.82 (s, 1H), 4.42 (s, 1H), 7.27–7.36 (m, 5H,
ArH), 7.49–7.57 (m, 2H, ArH), 7.61–7.66 (m, 1H,
ArH), 7.79–7.82 ppm (m, 2H, ArH). 13C NMR
(CDCl3): 25.9, 52.9, 73.8, 77.6, 126.7, 127.9, 128.5,
128.8, 129.2, 133.7, 138.9, 142.0 ppm. IR (KBr): 527,
736, 913, 1020, 1072, 1087, 1288, 1405, 1445, 1494,
1471, 2892, 3063, 3510 cm−1. Rf=0.41 (t-BuOMe/
CHCl3, 3:2). Anal. calcd for: C16H18O4S (M=306.38):
C, 62.72; H, 5.92; S, 10.46; found C, 63.04; H, 6.10, S,
10.73%.